# Global Variability in the Management of Inflammatory Bowel Disease: Towards Context-Specific Strategies

## TL;DR

This paper reviews how IBD management varies globally and suggests adapting strategies to local resources for better patient outcomes.

## Contribution

The paper provides a narrative review highlighting the need for context-specific IBD management strategies based on resource availability.

## Key findings

- IBD management is influenced by regional differences in resources and healthcare systems.
- Early diagnosis and dietary interventions can improve outcomes in IBD patients.
- Adaptable, patient-centred strategies are needed to optimize IBD care globally.

## Abstract

Inflammatory bowel diseases (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), are chronic, relapsing conditions with increasing prevalence worldwide, thought to be driven by socioeconomic and environmental factors. Managing IBD effectively across diverse healthcare settings remains a significant challenge, as there is no universal approach. Advances such as biologic therapies, biosimilars, and small molecule agents have improved outcomes; however, disparities in access, infrastructure, and costs persist, especially in resource-limited regions. As the therapeutic landscape expands, regional treatment hierarchies are increasingly shaped by resource availability, economic constraints, and healthcare system capacity. This narrative review synthesises current evidence and explores how resource availability influences treatment decision-making. It further discusses the potential of early diagnosis, preventive strategies, and dietary interventions to enhance patient outcomes and advance cost-effective care globally. Emphasising the importance of adaptable, patient-centred management, this narrative review aims to inform healthcare providers and policymakers on tailoring IBD care to maximise disease control and healthcare efficiency across diverse resource settings.